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DOI: http://dx.doi.org/101016/j.hemonc.2013.03.002BACKGROUND AND OBJECTIVES: The etiology of favism remains unclear and the fate of favic patients has
not previously been studied. Therefore, individuals who had experienced an episode of favism were studied
regarding subsequent fava bean ingestion, including the reason for fava bean ingestion after the initial favic
attack and any adverse reactions. In addition, a new hypothesis for the etiology of favism is proposed.
PATIENTS AND METHODS: From June 2005 to June 2012, a total of 38 patients with a history of favism were
included in this study. Circumstances regarding the initial favic attack were obtained from medical records and
patient interviews, and subsequent fava bean ingestion and recurrence of symptoms were investigated.
RESULTS: Three of the 38 patients (7.9%) were female, and 35 (92.1%) were male. The mean age was
27.9 years (14–63 years). The first attack of favism occurred before 10 years of age for 31 patients (81.6%)
and in the springtime for 35 patients (92.1%). Thirty-three patients (86.7%) regularly ate fava beans before
the attack, and 35 (92.1%) resumed eating fava beans within 1–17 years after the attack without symptoms.
Two patients (5.2%) experienced a single recurrence of symptoms. No evidence of hemolysis was found in
the four patients checked after fava bean re-ingestion.
CONCLUSIONS: Patients resumed eating fava bean for various reasons, and the recurrence of symptoms was
uncommon. An infectious agent such as a virus may play a role in the development of favism.HFavism, which is a severe hemolytic anemia thatoccurs after ingesting fava bean (FB), has beenknown since ancient times.1 In the mid-20th
century, a link between this disease and glucose-6-
phosphate dehydrogenase (G6PD) deﬁciency was dis-
covered.2 Since then favism has been considered to be
simply a manifestation of G6PD deﬁciency3 rather
than a distinct disorder.
Favism occurs most often in children aged 1–
5 years who have the Mediterranean type of G6PD
deﬁciency. It is uncommon in adults and those with
other types of G6PD deﬁciency.4–7 Although all
patients with favism are G6PD-deﬁcient, not all
G6PD-deﬁcient individuals develop hemolysis after
eating FB. Even in the same person, favism attacks
show a striking variability from one exposure to an-
other.8–10 Furthermore, favism does not recur in most
favic patients who later resume eating FB.5,7,11–13
Many favic patients ingest FB for years without any
harm before they develop favism.7,13 Although familialematol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncstem.edmgr.comaggregation of favism has been reported,5,7,11 another
study reports that family members of a favic patient
ate the same FB without ill effects, and these individu-
als were later found to be G6PD-deﬁcient.14
Epidemics of favism occur in the spring and during
FB harvest, with only sporadic cases occurring during
the rest of the year.4,5,11 It is most common after eat-
ing fresh FB, especially raw beans, but can occur after
eating frozen or dried FB.4,11 However, there are no
reports of favism associated with eating canned FB.
Favism has also occurred after inhaling fava pollen,
in lactating children a few days after their mothers
ate FB, and in neonates whose mothers ate FB a
few days before delivery.5,15–17 Clinical symptoms of
hemolytic anemia in favism occur 24–48 hours after
eating FB and can last up to 5 days.5,8,18 Favism does
not always cause severe symptoms; milder or ‘‘abor-
tive’’ forms exist and may be widespread.19 Various
causes have been proposed for the pathogenesis of
hemolysis in favism, such as toxic substances in the9
10
original research report A NEW HYPOTHESIS FOR FAVISM ETIOLOGY
FBs (e.g., vicine and convicine or their active aglycones
divicine and isouramil), hereditary factors, and immu-
nological factors. However, the clinical and epidemio-
logical evidence does not appear to be consistent with
these explanations.20 Thus, no convincing hypothesis
exists that can explain the erratic hemolytic episodes
seen in favism.4 The pathogenesis of favism appears
to be complex, suggesting that factor(s) other than
G6PD deﬁciency are involved.14,20 Few authors have
raised the possibility that favism could be a distinct
disease, and that the hemolysis that occurs in
G6PD deﬁciency may be a severe form of the
disease.13,20
To better understand this complex disease, I stud-
ied non-pediatric patients with a history of favism,
recurrence of symptoms after subsequent exposure
to FBs, and the reasons for subsequent FB ingestion
if occurred. In addition, I propose a new hypothesis
for the pathogenesis of this disease.PATIENTS AND METHODS
This study was conducted at the Al-Ramadi General
Teaching Hospital in Al-Ramadi city, western Iraq
from June 2005 to June 2012. Patients with a history
of favism were recruited from the outpatient clinic.
For patients who agreed to participate, all available re-
cords in the Al-Ramadi Pediatric Teaching Hospital
and Al-Ramadi General Teaching Hospital were re-
viewed. The purpose of the study was explained to
all participants, their addresses and cell phone num-
bers were obtained for interviews. All participants
were screened for G6PD deﬁciency by the ﬂuorescent
spot test;21 those with negative test results were ex-
cluded from the study. A detailed history was ob-
tained from all patients regarding their favism
attack(s), including time of onset, hospital admission,
any blood transfusions, consumption of FB before and
after the initial attack, recurrence of favism, hemolysis
after drug ingestion, and family history. All available
records related to the illness or laboratory tests were
reviewed. In addition, complete blood counts, includ-
ing reticulocyte count and blood ﬁlm, were obtained
for all participants at the time of the study. Four male
patients, who resumed FB ingestion at a previous
date, agreed to have a single blood test after ingesting
fresh FB. They contacted me after ingesting FB to ar-
range the blood test. All these patients were tested
during the time of FB harvest and all had ingested a
moderate amount of fresh boiled FB. Hemoglobin lev-
els, reticulocyte count, and serum bilirubin levels were
checked for these four patients within 2.5–5 days
after ingestions.HeSimple statistical analysis needed in this paper was
performed using SPSS version 14.RESULTS
A total of 44 patients were recruited for this study,
but six were excluded because they were not G6PD-
deﬁcient. Of the remaining 38 patients, there were
three females (7.9%) and 35 males (92.1%). The mean
age was 27.9 years (14–63 years). Hospital records
for 21 patients were available at the Al-Ramadi
General Teaching Hospital and the Al-Ramadi
Pediatric Teaching Hospital. Table 1 summarizes
the clinical and demographic data of the participants.
Thirty-one patients (81.6%; female, n = 2; male,
n = 29) experienced their ﬁrst favism attack before
the age of 10 years (2–9 years), whereas seven
(18.4%; female, n = 1; male n = 6) experienced their
ﬁrst favism attack after the age of 10 years (14–
61 years). Thirty-ﬁve patients (92.1%) developed
favism in the spring according to patient history or
records. Three patients did not remember when the
attack of favism occurred, and no hospital records
were available for these patients. All patients or their
families reported that favism attacks occurred within
1–6 days of eating fresh cooked or uncooked FB.
No patient had an attack after eating frozen, dried,
or canned FBs. Three patients (7.9%; female, n = 1;
male, n = 2) had a positive family history of favism.
Only two patients (5.2%) experienced a second attack.
The ﬁrst was a female patient with a positive family
history of favism. Her ﬁrst attack was mild and
occurred in spring when she was 2.5 years old; the
second attack was severe and occurred in the spring
when she was 6 years old. The second was a male
patient with a positive family history; he was a relative
of the ﬁrst patient. His ﬁrst favism attack was moder-
ately severe and occurred at age of 1.5 years, according
to his mother. The second attack was mild and
occurred at age of 9 years. None of the patients whose
ﬁrst favism attack occurred when they were older than
10 years experienced another attack after subsequent
FB ingestion. Thirty-three patients (86.8%) reported
that they were able to eat FB without any problems
before the ﬁrst favism attack occurred, and ﬁve
patients (13.1%) did not know if they had consumed
FBs before the attack.
After the initial favism attack, 35 patients (92.1%)
consumed FB within 1–17 years (mean 7.1 ±
3.74 years), including one patient who had a second
favism attack. She resumed eating FB within 1 year
after the ﬁrst attack, and resumed eating FB 11 yearsmatol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncstem.edmgr.com
Table 1. Main data of favism cases.
No. %
Age (years)
14–20 7 18.4
20–29 12 31.6
30–39 11 28.9
40–49 6 15.8
50 & above 2 5.3
Total 38 100
Sex
Male 35 92.1
Female 3 7.9
Age at first occurrence
10 years of age 31 81.6
>10 years of age 7 18.4
Recurrence of favism
At least once 2 5.2
None 36 94.8
Seasonal occurrence
At spring 35 92.1
During other seasons 0 0
Do not know the time 3 7.9
Family history
Positive 3 7.9
Negative 35 92.1
FB ingestion
Before favism attacks 33 86.1
After favism attacks 35 92.1
A NEW HYPOTHESIS FOR FAVISM ETIOLOGY original research reportafter the second attack. As shown in Table 2, the
reasons given for eating FB after being warned of
recurrence of favism were: (1) accidental ingestion
(n = 5, 13.1%) for patients younger than 9 years; (2)
suggestion of another person (n = 4, 10.5%); (3) inten-
tional gradual reintroduction of FBs into the diet to testHematol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncstem.edmgr.comwhether hemolysis would develop (n = 11, 28.9%); (4)
did not believe long-term avoidance was necessary
(n = 7, 18.4%); and (5) forgot about the illness or
thought it would subside over time (n = 8, 21%).
Three patients avoided FB after the initial favism
attack. Two had experienced their ﬁrst favism attack
as adults, and the third had a second favism attack,
and avoided FB after that. No patient had a history
of drug-induced hemolysis. At the time of the study,
all blood counts were within normal limits, including
reticulocyte counts.
No signiﬁcant changes in blood indices and serum
bilirubin were found in any of the four patients tested
after FB ingestion (Table 3).DISCUSSION
Although favism has long been known, its pathogen-
esis is not well understood. Few large studies or re-
views of this disease have been published. In this
study I evaluated non-pediatric patients with a history
of favism, concentrating on subsequent FB consump-
tion, to better understand disease behavior over time.
The six patients excluded from the study are all male,
none of them had G6PD test before, and admitted to
hospital as cases of hemolytic anemia at the time of
FB harvest. The diagnosis was clinical one, and mostly
there was another cause for this hemolysis.
Consistent with results of previous studies, most of
the patients were male (92.1%), which was expected
because G6PD deﬁciency is a sex-linked condi-
tion,5,13,22,19 and most experienced their ﬁrst attack
of favism during childhood (81.6% were younger than
10 years).5,13,22 Most of the patients had consumed
FBs more than once before favism occurred and had
the hemolytic crisis during spring, as reported by
other researchers.5,7,9,13–16 None of the patients in
this study had a history of drug-induced hemolysis.
Although 35 patients consumed FB after the ﬁrst
favism attack, only two patients experienced another
attack. Only a few studies have reported the effects
of FB ingestion in individuals who previously experi-
enced an attack of favism. Yahya et al. challenged
three favic patients with FB, observing no adverse
reactions during the 1-month follow-up.13 Kattamis
et al. reported that most patients who have favism
at ﬁrst exposure later ingested beans without unto-
ward effects; a second attack of favism occurred in
only 10 of the 120 patients studied.5
These ﬁndings cannot be explained by the proposed
etiologies for favism. Although favism is considered an
inherited disease,12 only three study participants had a
positive family history of favism. It is of interest that the11
Table 2. Behavior of cases regarding FB re-ingestion in favic patients.
Type of behavior regarding FB re-ingestion No.
Accidental ingestion 5 (13.1%)
Re-ingestion by suggestion of someone 4 (10.5%)
Intentional gradual re-ingestion 11 (28.9%)
Did not believe in avoidance, or think the avoidance is transient 7 (18.4%)
Forgot the illness over time or thought that the disease disappeared by time 8 (21%)
Stick to avoidance of FB 3 (7.9%)
12
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vism were related to each other. Toxic substances in
FB, a predisposing autosomal gene, or immunological
causes do not fully explain the features of favism. None
of the suggested causes can explain why hemolysis does
not occur each time FB is ingested or why favism occurs
primarily in children, in the springtime, and after eating
fresh FB. If any of the proposed etiologies were true,
then all patients should have a hemolytic crisis every
time they ingest FBs.
For that reason, we must look for new mechanisms
underlying the onset of favism. In 1993 Yahya et al.
suggested that a virus may contribute to the pathogen-
esis of favism.13 Moreover, Belsey et al. reported that
the temporal distribution of favism cases resembles
that of an infectious disease, in which the sudden
introduction of an agent into a susceptible population
leads to the rapid appearance of cases, followed by a
less rapid decline.7 It is clear that G6PD deﬁciency
is necessary for the severe hemolytic crises seen in fa-
vism, but most researchers agree that another factor(s)
must be involved.13,14,20 Although both G6PD deﬁ-
ciency and FB consumption are common throughout
the world, favism is not common. For example,
G6PD deﬁciency was found in 26.4% of Egyptian
males, but the incidence of favism is not high in that
country even though imported FBs are mixed with lo-
cal horse beans and consumed by nearly all Egyp-
tians.23 Ho et al. suggested that G6PD deﬁciency
enhances the cytopathic effects of viral infection and
increases the number of progeny viruses, potentially
making G6PD-deﬁcient individuals more susceptible
to viral infections.24 Furthermore, infection is the
most common cause of hemolysis in G6PD
deﬁciency.9,10,15
Therefore, I propose a new hypothesis for the
pathogenesis or etiology of favism that explains all
or most of the points mentioned. My hypothesis is
that the cause of hemolytic anemia in favism is anHeinfectious agent, probably a virus. The behavior of fa-
vism is similar to that of measles in many ways. Mea-
sles is viral infection that occurs primarily in the
spring, confers permanent or partial immunity, and
occurs most often in children (before the era of vacci-
nation) but only sporadically in adults. It is possible
that favism is caused by an infectious agent such as
a virus that appears in spring in certain regions of
the world, and that this infectious agent is associated
in some way with the FB plant. Thus an individual
with severe G6PD deﬁciency (especially Mediterra-
nean type) exposed to this pathogen for the ﬁrst time
may develop severe hemolysis. Individuals who survive
become completely or partially immune to this infec-
tion in the future. If proven, this infectious etiology of
favism and the acquired immunity would explain most
of the previously unexplained features of the disease.
Favism occurs most often in spring, the time of
appearance of the supposed pathogen, and the ac-
quired immunity in childhood makes it a pediatric
disease. Previous exposure to FBs in the absence of
the hypothetical pathogen explains why favism does
not always occur the ﬁrst time FB are ingested, and
the acquired immunity explains why hemolysis does
not usually recur if FB are eaten after a favic attack.
The sporadic cases in adults could be explained by
lack of previous exposure to the hypothetical patho-
gen. The development of favism after pollen inhala-
tion can also be explained by an infectious etiology.
If this proposed etiology is true, then FB does not di-
rectly cause hemolysis. In support of this hypothesis,
ﬁrst the ingestion of fresh FB in four patients here
does not cause any evidence of hemolysis, and sec-
ondly in the years 2008–2011, fresh FB were brought
to market in the city of Al-Ramadi in early December,
but no favism cases appeared until the following
spring. Similar to many reported cases, the illness
started with mild constitutional symptoms similar to
those of an infection.15,25matol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncstem.edmgr.com
Table 3. Hemoglobin level, reticulocyte percentage and serum bilirubin after fresh FB ingestion in four patients.
Patient 1 Patient 2 Patient 3 Patient 4
Age (year) 19 26 36 39
Time of blood test after FB ingestion (days) 4 2.5 3.5 4.5
Hemoglobin gm/dL 12.9 14.9 13.5 13.9
Reticulocyte (%) 0.8 1.2 1 1.3
Total serum bilirubin mg/dL 1.1 1.3 1.3 0.9
Hemoglobin before FB ingestion1 gm/dL 13.2 14.3 13.9 13.3
1Hemoglobin level at an older date ranges between three months and 2 years.
A NEW HYPOTHESIS FOR FAVISM ETIOLOGY original research reportFB is an important and inexpensive protein source.
However, people from Mediterranean countries, and
perhaps other regions of the world, are often afraid
to eat FB. Therefore, it is important to understand
that recurrence of favism is not common. Additional
studies needed to better understand the underlying
mechanisms associated with this disease.CONCLUSIONS
Favism does not typically recur after subsequent FB
ingestion. The pathogenesis of favism cannot be ex-Hematol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncstem.edmgr.complained by G6PD deﬁciency alone but suggests the
involvement of an infectious agent such as a virus.
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